Cardioprotection for type II diabetic patients undergoing cardiopulmonary bypass: a comparison of 2 different anaesthetic agents.

Phase 4

• Conditions: Postoperative myocardial damage; Metabolic and Endocrine - Diabetes; Cardiovascular -

• Registration Number: ACTRN12605000677606
• Lead Sponsor: Dept of Anaesthesia

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-10-21
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Non insulin dependent diabetes mellitus patients, undergoing routine, primary coronary artery bypass graft surgery requiring cardiopulmonary bypass.

Exclusion Criteria

Those with a sensitivity to propofol or its components, acute or evolving myocardial infarction, peroperative haemodynamic instability, hepatorenal dysfunction, off pump or valvular surgery.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood measurement of the enzyme cardiac troponin i [At 12 and 24 hours post-admission to the intensive care unit after coronary artery bypass graft surgery.]

Secondary Outcome Measures

Name	Time	Method
Inotrope use and other haemodynamic support, haemodynamic data.[In the first 24 hours postoperatively.]